David Galey

430 total citations
9 papers, 296 citations indexed

About

David Galey is a scholar working on Virology, Molecular Biology and Physiology. According to data from OpenAlex, David Galey has authored 9 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 4 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in David Galey's work include HIV Research and Treatment (6 papers), HIV-related health complications and treatments (3 papers) and Signaling Pathways in Disease (2 papers). David Galey is often cited by papers focused on HIV Research and Treatment (6 papers), HIV-related health complications and treatments (3 papers) and Signaling Pathways in Disease (2 papers). David Galey collaborates with scholars based in United States. David Galey's co-authors include Avindra Nath, Mark P. Mattson, Avindra Nath, Katherine Conant, Coryse St. Hillaire, Norman J. Haughey, Jerold G. Woodward, Caroline Anderson, Jessica Wang and Audrey N. Kalehua and has published in prestigious journals such as The FASEB Journal, Journal of Neurochemistry and Vaccine.

In The Last Decade

David Galey

9 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Galey United States	8	190	113	88	51	35	9	296
Arpita Nath United States	7	228 1.2×	101 0.9×	130 1.5×	46 0.9×	62 1.8×	11	409
Odell D. Jones United States	11	113 0.6×	124 1.1×	62 0.7×	61 1.2×	29 0.8×	27	343
Shaily Malik United States	11	120 0.6×	165 1.5×	72 0.8×	37 0.7×	20 0.6×	13	326
Lisa A. Ryan United States	7	181 1.0×	53 0.5×	158 1.8×	108 2.1×	41 1.2×	8	316
Carmen Teodorof‐Diedrich United States	9	102 0.5×	149 1.3×	58 0.7×	45 0.9×	43 1.2×	10	357
Valeria Avdoshina United States	12	216 1.1×	129 1.1×	106 1.2×	36 0.7×	71 2.0×	20	381
Linda M. Dallasta United States	5	164 0.9×	113 1.0×	254 2.9×	69 1.4×	37 1.1×	5	428
Paul Castellano United States	9	229 1.2×	141 1.2×	91 1.0×	76 1.5×	29 0.8×	11	409
Ricky Maung United States	11	293 1.5×	68 0.6×	220 2.5×	95 1.9×	42 1.2×	16	413
H. J. James United States	6	224 1.2×	114 1.0×	176 2.0×	129 2.5×	63 1.8×	8	428

Countries citing papers authored by David Galey

Since Specialization

Citations

This map shows the geographic impact of David Galey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Galey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Galey more than expected).

Fields of papers citing papers by David Galey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Galey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Galey. The network helps show where David Galey may publish in the future.

Co-authorship network of co-authors of David Galey

This figure shows the co-authorship network connecting the top 25 collaborators of David Galey. A scholar is included among the top collaborators of David Galey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Galey. David Galey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Steiner, Joseph, et al.. (2007). Neuroprotective and Antiretroviral Effects of the Immunophilin ligand GPI 1046. Journal of Neuroimmune Pharmacology. 2(1). 49–57. 7 indexed citations

2.

Patel, Jigna D., David Galey, Jeffrey M. Jones, et al.. (2006). HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. Vaccine. 24(17). 3564–3573. 26 indexed citations

3.

Nath, Avindra, John T. Slevin, David Galey, et al.. (2006). The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV‐1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. Journal of Neurochemistry. 98(1). 146–155. 25 indexed citations

4.

Rumbaugh, Jeffrey A., Jadwiga Turchan‐Cholewo, David Galey, et al.. (2006). Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism. The FASEB Journal. 20(10). 1736–1738. 37 indexed citations

5.

Christian, David A., et al.. (2005). Selective Isolation and Purification of Tat Protein via Affinity Membrane Separation. Biotechnology Progress. 21(2). 451–459. 21 indexed citations

6.

Galey, David, et al.. (2005). Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotoxicity Research. 8(1-2). 119–134. 69 indexed citations

7.

Conant, Katherine, Coryse St. Hillaire, Caroline Anderson, et al.. (2004). Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Journal of NeuroVirology. 10(1). 21–28. 56 indexed citations

8.

Galey, David, Kevin G. Becker, Norman J. Haughey, et al.. (2003). Differential Transcriptional Regulation by Human Immunodeficiency Virus Type 1 and gp120 in Human Astrocytes. Journal of NeuroVirology. 9(3). 358–371. 49 indexed citations

9.

Galey, David, Kevin G. Becker, Norman J. Haughey, et al.. (2003). Differential Transcriptional Regulation by Human Immunodeficiency Virus Type 1 and gp120 in Human Astrocytes. Journal of NeuroVirology. 9(3). 358–371. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact